Leqembi™ (lecnemab-irmb) injection
Approval Date: Jan 2023
Indicated for the treatment of Alzheimer’s in patients with mild cognitive impairment or mild dementia sage of the disease
Adlarity (donepezil hydrochloride) transdermal system
Approval Date: Mar 2022
Indicated for the treatment of mild-to-severe dementia of the Alzheimer’s type. This product is the first transdermal patch for this indication.
ADUHELM™ (ADUCANUMAB-AVWA) INJECTION
Approval Date: Jun 2021
A first-of-its-kind, biologic treatment for Alzheimer’s disease. This drug is the first new Alzheimer’s drug since 2003